Pro-FMRFamide-related neuropeptide FF

Also known as: FMRFamide-related peptides, NPFF, O15130

Pro-FMRFamide-related neuropeptide FF (NPFF) is a precursor protein that gives rise to several bioactive peptides, including neuropeptide FF (NPFF) and neuropeptide AF (NPAF). These peptides are primarily known for their role in modulating opioid-induced analgesia, acting as endogenous anti-opioid agents. The mechanism involves binding to specific G-protein-coupled receptors, NPFF1 and NPFF2, which are widely distributed in the central nervous system. Activation of these receptors can counteract morphine-induced analgesia, elevate arterial blood pressure, and stimulate somatostatin secretion from the pancreas, indicating a broad range of physiological effects beyond pain modulation. Key research findings indicate that NPFF and related peptides can both enhance and inhibit opioid effects depending on the dose, route of administration, and receptor subtype involved. For example, low doses may potentiate morphine analgesia, while higher doses reverse it. Additionally, NPFF has been implicated in cardiovascular regulation, with studies showing its ability to increase blood pressure via central and peripheral mechanisms. The peptide also influences neuroendocrine function, particularly by promoting somatostatin release, which may affect glucose homeostasis and gastrointestinal activity. Clinically, NPFF and its analogs are of interest for developing novel analgesics and treatments for opioid tolerance and dependence. However, due to its complex, dose-dependent effects on pain and cardiovascular systems, therapeutic applications remain experimental. Further research is needed to clarify receptor-specific actions and potential side effects before clinical translation. For research purposes only — not medical advice.

Key data

Mechanism of action

Morphine modulating peptides. Have wide-ranging physiologic effects, including the modulation of morphine-induced analgesia, elevation of arterial blood pressure, and increased somatostatin secretion from the pancreas. Neuropeptide FF potentiates and sensitizes ASIC1 and ASIC3 channels

Frequently asked questions

Related peptides